Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Hartmann

Showing results (241-250 of 251) with videos related to

Pageof 26
Sort By:
Leukemia|January 21, 2006
Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemiaM Ritter, D Kattmann, S Teichler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology studyF Pein, J Michon, D Valteau-Couanet, et al.
British Journal of Cancer|July 2, 1998
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)H Rubie, J Michon, D Plantaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie PédiatriqueH Rubie, O Hartmann, J Michon, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 19, 2020
Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic MastocytosisJuliana Schwaab, Nicole Cabral do O Hartmann, Nicole Naumann, et al.
Optics Express|July 1, 2010
Experimental demonstration of a synthetic aperture compression scheme for multi-Petawatt high-energy lasersN Blanchot, E Bar, G Behar, et al.
International Journal of Cancer|March 27, 2001
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplificationD Plantaz, J Vandesompele, N Van Roy, et al.
British Journal of Cancer|September 20, 2000
Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French society of pediatric oncologyV Minard, O Hartmann, M C Peyroulet, et al.
Cancer Research|February 11, 1998
A lack of neuroblastoma in Down syndrome: a study from 11 European countriesD Satgé, A J Sasco, N L Carlsen, et al.
Blood|November 10, 1998
Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working PartyE Carreras, H Bertz, W Arcese, et al.
Pageof 26

Showing results (241-250 of 251) with videos related to

Sort By:
Pageof 26
Leukemia|January 21, 2006
Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemiaM Ritter, D Kattmann, S Teichler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology studyF Pein, J Michon, D Valteau-Couanet, et al.
British Journal of Cancer|July 2, 1998
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)H Rubie, J Michon, D Plantaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie PédiatriqueH Rubie, O Hartmann, J Michon, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 19, 2020
Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic MastocytosisJuliana Schwaab, Nicole Cabral do O Hartmann, Nicole Naumann, et al.
Optics Express|July 1, 2010
Experimental demonstration of a synthetic aperture compression scheme for multi-Petawatt high-energy lasersN Blanchot, E Bar, G Behar, et al.
International Journal of Cancer|March 27, 2001
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplificationD Plantaz, J Vandesompele, N Van Roy, et al.
British Journal of Cancer|September 20, 2000
Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French society of pediatric oncologyV Minard, O Hartmann, M C Peyroulet, et al.
Cancer Research|February 11, 1998
A lack of neuroblastoma in Down syndrome: a study from 11 European countriesD Satgé, A J Sasco, N L Carlsen, et al.
Blood|November 10, 1998
Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working PartyE Carreras, H Bertz, W Arcese, et al.
Pageof 26